Molecular Partners AG (MOLN)
MOLN Stock Price Chart
Explore Molecular Partners AG interactive price chart. Choose custom timeframes to analyze MOLN price movements and trends.
MOLN Company Profile
Discover essential business fundamentals and corporate details for Molecular Partners AG (MOLN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Jun 2021
Employees
158.00
CEO
Patrick Amstutz
Description
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, which is in Phase Ia clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive cancers. It also develops MP0423 for treating COVID-19; MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Molecular Partners AG has agreements and collaboration with Novartis AG to develop, manufacture, and commercialize DARPin-conjugated radioligand therapies; Amgen SA; Allergan, Inc.; and discovery alliance with AbbVie Inc. in ophthalmology, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.
MOLN Financial Timeline
Browse a chronological timeline of Molecular Partners AG corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 Mar 2026
Upcoming earnings on 30 Oct 2025
EPS estimate is -$0.53.
Earnings released on 25 Aug 2025
EPS came in at -$0.67 falling short of the estimated -$0.53 by -26.42%.
Earnings released on 15 May 2025
EPS came in at -$0.50 falling short of the estimated -$0.42 by -18.64%.
Earnings released on 6 Mar 2025
EPS came in at -$0.34 surpassing the estimated -$0.44 by +22.73%.
Earnings released on 31 Oct 2024
EPS came in at -$0.57 surpassing the estimated -$0.63 by +9.52%, while revenue for the quarter reached $810.23K , beating expectations by +1.28%.
Earnings released on 26 Aug 2024
EPS came in at -$0.51 surpassing the estimated -$1.26 by +59.52%, while revenue for the quarter reached $1.73M , beating expectations by +95.70%.
Earnings released on 16 May 2024
EPS came in at -$0.39 , while revenue for the quarter reached $3.02M , beating expectations by +1.28%.
Earnings released on 14 Mar 2024
EPS came in at -$0.68 surpassing the estimated -$0.97 by +29.90%, while revenue for the quarter reached $1.21M , missing expectations by -31.08%.
Earnings released on 26 Oct 2023
EPS came in at -$0.40 , while revenue for the quarter reached $2.77M , beating expectations by +81.91%.
Earnings released on 23 Aug 2023
EPS came in at -$0.55 , while revenue for the quarter reached $462.67K , missing expectations by -74.14%.
Earnings released on 12 May 2023
EPS came in at -$0.49 , while revenue for the quarter reached $3.33M , beating expectations by +84.88%.
Earnings released on 9 Mar 2023
EPS came in at -$0.56 falling short of the estimated $0.90 by -162.22%, while revenue for the quarter reached $2.91M , missing expectations by -35.53%.
Earnings released on 27 Oct 2022
EPS came in at -$0.42 surpassing the estimated -$0.66 by +35.97%, while revenue for the quarter reached $2.37M , missing expectations by -28.52%.
Earnings released on 25 Aug 2022
EPS came in at -$0.15 surpassing the estimated -$0.66 by +77.13%, while revenue for the quarter reached $12.26M , beating expectations by +0.20%.
Earnings released on 12 May 2022
EPS came in at $4.99 surpassing the estimated -$0.66 by +860.76%, while revenue for the quarter reached $186.63M , beating expectations by +4.32%.
Earnings released on 15 Mar 2022
EPS came in at -$0.56 surpassing the estimated -$1.04 by +46.15%, while revenue for the quarter reached $14.56M , missing expectations by -5.03%.
Earnings released on 28 Oct 2021
EPS came in at -$0.41 , while revenue for the quarter reached $3.79M .
Earnings released on 26 Aug 2021
EPS came in at -$0.60 , while revenue for the quarter reached $3.48M .
Earnings released on 16 Jun 2021
EPS came in at -$0.60 , while revenue for the quarter reached $865.28K .
Earnings released on 26 Feb 2021
EPS came in at -$0.65 , while revenue for the quarter reached $307.74K .
Earnings released on 31 Dec 2020
EPS came in at -$0.98 , while revenue for the quarter reached $1.75M .
MOLN Stock Performance
Access detailed MOLN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.